Delivery Order SPE2DR25D1104-SPE2DR26FK642
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $63,277.60 under a firm fixed price contract. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.10 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,590.44 to supply Prevnar 20 syringes (0.5mL) with a firm fixed price and December 8, 2025 completion date. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $32,879.40 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe vaccine supply (0.5ml units) on August 22, 2025, with completion targeted for August 25, 2025. This competitive award utilizes firm fixed pricing under a child contract vehicle and involves no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,281.88 to supply PREVNAR 20 syringes (0.5ML) under a firm fixed price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.94 to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5mL) on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for PREVNAR 20 syringes (10-pack). This firm fixed price delivery order, valued at $16,337.70, represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under the company's...
- The Defense Logistics Agency awarded a $18,641.67 delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of September 8, 2025. This non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $33,261.69 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK642Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringe (0.5ML) under a firm fixed-price contract valued at $16,084.08, with an ultimate completion date of December 15, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through its extensive contract portfolio with the Defense Logistics Agency. PREVNAR 20 is a pneumococcal vaccine used to protect against pneumococcal disease, aligning with the company's demonstrated capability to deliver vaccines and specialized medical commodities across multiple therapeutic domains to support federal healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 12/11/25 |